construct
herp
simplex
viru
bacteri
artifici
chromosom
bac
describ
bac
vector
sequenc
insert
thymidin
kinas
gene
homolog
recombin
dna
cell
infect
result
recombin
viru
transform
e
coli
coloni
contain
bac
isol
analyz
expect
genotyp
dna
infecti
transfect
back
mammalian
cell
result
viru
thymidin
kinas
neg
use
immun
mice
dna
elicit
strong
specif
antibodi
respons
equal
greater
live
viru
immun
immun
protect
anim
challeng
lethal
dose
viru
util
construct
recombin
viru
genom
demonstr
elimin
glycoprotein
gd
gene
recombin
bac
gd
gene
delet
isol
shown
incap
produc
infecti
viru
follow
transfect
unless
hsv
gd
gene
express
complement
cell
line
immun
mice
gdbac
also
elicit
specif
antibodi
respons
protect
result
demonstr
feasibl
dna
immun
bacteri
artifici
chromosom
replic
nonrepl
candid
vaccin
well
util
bac
technolog
construct
mainten
novel
vaccin
result
suggest
technolog
power
tool
dissect
immun
respons
sever
larg
dna
rna
virus
clone
bacteri
artifici
chromosom
bac
includ
poxvirus
domi
moss
herpesvirus
eg
epsteinbarr
viru
deleclus
et
al
human
mous
cytomegalovirus
borst
et
al
messerl
et
al
pseudorabi
viru
smith
enquist
herp
simplex
viru
horsburgh
et
al
saeki
et
al
stavropoulo
strathde
coronavirus
eg
transmiss
gastroenter
almazan
et
al
major
util
construct
recombin
viral
bac
result
eas
viral
genom
manipul
prokaryot
genet
techniqu
construct
recombin
virus
exampl
essenti
nonessenti
viru
gene
rapidli
identifi
without
construct
complement
cell
line
brune
et
al
furthermor
manipul
perform
dna
clone
prokaryot
system
chanc
isol
recombin
genom
unrel
mutat
reduc
sinc
mutat
genom
exist
dna
clone
sequenc
analysi
recombin
facilit
plaqu
purif
result
recombin
viru
requir
viral
bac
could
also
potenti
use
immun
theori
bac
contain
entir
genom
nonrepl
viru
could
use
deliv
almost
entir
spectrum
viral
gene
dna
vaccin
approach
use
nonrepl
bac
recent
describ
suter
et
al
howev
futur
dna
vaccin
still
clear
dna
vaccin
shown
promis
anim
studi
util
human
yet
proven
nevertheless
dna
vaccin
particularli
express
numer
antigen
elicit
broad
immun
respons
mimic
natur
infect
may
role
new
gener
vaccin
possibl
part
novel
primeboost
combin
use
vector
addit
deliveri
nonrepl
viral
genom
bac
could
also
use
deliv
genom
replic
viru
live
viru
immun
advantag
eg
good
immunogen
stimul
humor
cellular
immun
disadvantag
eg
safeti
concern
potenti
viru
latenc
persist
live
viru
vaccin
well
known
mainten
live
viru
vaccin
dna
form
bac
would
offer
addit
advantag
gener
product
live
viru
vaccin
major
advantag
note
construct
newgener
viru
vaccin
would
facilit
addit
viral
vaccin
stock
could
rederiv
necessari
transfect
bac
dna
new
qualifi
cell
line
thu
elimin
concern
regard
potenti
contamin
undocu
viru
seed
histori
final
viral
vaccin
could
produc
deliv
dna
concern
cell
substrat
use
vaccin
product
includ
tumorigen
presenc
unknown
adventiti
agent
could
elimin
describ
construct
herp
simplex
viru
bac
evalu
abil
dna
construct
immun
mice
protect
lethal
challeng
demonstr
util
bac
system
construct
new
genom
engin
nonrepl
glycoprotein
gd
neg
final
show
dna
immun
gdneg
bac
dna
also
elicit
protect
immun
respons
thu
bac
technolog
provid
mechan
dissect
character
contribut
individu
viral
gene
gener
protect
immun
clone
genom
bacteri
artifici
chromosom
construct
plasmid
insert
vector
insert
e
coli
ffactor
replicon
viral
genom
insert
plasmid
design
fig
contain
sequenc
includ
ffactor
origin
replic
choramphenicol
acetyltransferas
cat
gene
regulatori
gene
necessari
replic
mainten
low
copi
number
e
coli
host
addit
sequenc
flank
two
approxim
fragment
sequenc
around
thymidin
kinas
tk
gene
design
target
belobac
sequenc
tk
locu
insert
homolog
recombin
recombin
gener
cotransfect
genom
dna
vero
cell
follow
select
thymidin
kinas
neg
viru
presenc
acyclovir
fig
schemat
diagram
structur
belobac
vector
sequenc
insert
thymidin
kinas
gene
via
homolog
recombin
insert
vector
singl
xhoi
restrict
site
belobac
approxim
kb
hindiii
site
use
insert
tk
gene
two
independ
viru
plaqu
carri
chloramphenicol
gene
identifi
replaqu
one
time
prepar
infect
cell
dna
use
transform
e
coli
chloramphenicolresist
coloni
obtain
two
origin
viru
recombin
select
analyz
presenc
belobac
sequenc
dna
two
independ
clone
deriv
two
independ
viru
recombin
analyz
restrict
enzym
analysi
southern
blot
verifi
structur
insert
sequenc
thymidin
kinas
tk
gene
fig
tk
gene
locat
within
xhoi
fragment
coordin
genbank
access
number
fig
lane
insert
belobac
sequenc
contain
singl
xhoi
site
follow
digest
xhoi
result
tkand
belobacposit
fragment
approxim
bp
fig
b
lane
dna
isol
infecti
transfect
vero
cell
approxim
plaqueform
unit
pfu
viru
produc
transfect
ag
dna
data
shown
viru
deriv
dna
replic
slightli
lower
level
wildtyp
vero
cell
viru
thymidin
kinas
defici
expect
shown
abil
replic
presenc
acyclovir
fig
determin
feasibl
immun
use
dna
deliv
dna
gene
gun
compar
immun
respons
live
viru
immun
four
group
mice
immun
either
ag
dna
pfu
viru
pfu
viru
ag
control
dna
pbelobac
serum
sampl
obtain
week
later
analyz
presenc
specif
antibodi
fig
singl
inocul
g
dna
result
readili
detect
specif
igg
respons
anim
inocul
pfu
viru
two
five
anim
inocul
one
time
lower
dose
viru
respond
detect
specif
igg
three
week
immun
group
anim
boost
dose
dna
viru
receiv
first
immun
sera
collect
week
later
second
immun
either
dna
viru
mice
vaccin
group
seroconvert
increas
mean
igg
titer
group
observ
rel
larg
variabl
specif
antibodi
respons
group
receiv
lower
dose
viru
like
reflect
poor
initi
respons
three
five
anim
analysi
sera
obtain
two
immun
either
dna
pfu
viru
reveal
high
titer
group
indic
broad
humor
immun
respons
type
immun
fig
specif
detect
five
anim
dnaimmun
group
two
five
anim
virusimmun
group
addit
sera
obtain
two
immun
either
dna
pfu
viru
capabl
neutral
vitro
f
f
p
mean
neutral
titer
log
respect
final
mice
immun
dna
surviv
lethal
challeng
five
five
four
five
p
anim
receiv
higher
dose
viru
fig
experi
shown
fig
three
five
anim
group
receiv
lower
dose
one
mous
group
receiv
higher
dose
viru
succumb
viru
challeng
anim
lowest
hsvspecif
igg
antibodi
level
two
immun
respect
group
data
shown
three
anim
lowdos
group
anim
without
detect
hsv
antibodi
one
immun
suggest
rough
correl
antibodi
respons
protect
lethal
challeng
taken
togeth
analys
indic
gene
gun
deliveri
dna
elicit
strong
hsvspecif
antibodi
respons
substanti
protect
lethal
challeng
equival
greater
live
viru
immun
one
major
advantag
clone
larg
viru
bacteri
artifici
chromosom
fig
antibodi
respons
follow
immun
dna
mice
immun
two
time
ag
dna
pfu
viru
pfu
viru
ag
pbelobac
control
dna
result
repres
experi
two
experi
similar
design
outcom
shown
group
consist
five
anim
specif
igg
determin
individu
mice
week
follow
first
immun
week
follow
booster
immun
dose
either
dna
viru
number
mice
detect
igg
titer
indic
less
five
calcul
mean
igg
titer
includ
valu
seroneg
anim
b
titer
specif
igg
isotyp
determin
week
immun
ag
dna
dna
pfu
viru
viru
number
mice
detect
antibodi
titer
indic
less
five
calcul
mean
igg
titer
includ
valu
seroneg
anim
eas
construct
recombin
viral
genom
recombin
genom
might
find
use
newer
gener
live
viru
vaccin
investig
eas
manipul
construct
replicationincompet
genom
miss
essenti
glycoprotein
gene
allow
us
determin
feasibl
bac
immun
replicationincompet
viru
also
investig
immunogen
absenc
one
major
immunodomin
viral
antigen
delet
gene
construct
gene
replac
plasmid
vector
contain
approxim
kb
dna
sequenc
upstream
gdcode
region
link
approxim
kb
sequenc
immedi
downstream
gdcode
region
gd
sequenc
target
vector
gd
region
delet
gdcode
region
addit
replac
vector
contain
temperaturesensit
origin
replic
marker
gene
posit
neg
select
bac
mutagenesi
procedur
describ
previous
horsburgh
et
al
horsburgh
et
al
absenc
gd
gene
mutagen
confirm
pcr
analysi
see
materi
method
result
gdbac
infecti
dna
transfect
vero
cell
pfuml
per
gram
transfect
dna
infecti
transfect
vero
cell
line
express
gd
data
shown
result
verifi
genotyp
result
phenotyp
replicationincompet
gdbac
although
miss
one
major
immunodomin
gdbac
dna
glycoprotein
obviou
interest
determin
abil
gdbac
dna
elicit
immun
respons
immun
anim
mice
immun
two
time
interv
gene
gun
inocul
ag
control
dna
pbelobac
vector
dna
gdbac
dna
specif
igg
antibodi
detect
follow
immun
gdbac
dna
fig
sera
obtain
two
immun
either
gdbac
dna
capabl
neutral
infect
vitro
f
f
p
mean
neutral
titer
log
respect
furthermor
mice
immun
either
dna
gdbac
dna
surviv
lethal
challeng
fig
recent
report
herpesviru
genom
clone
maintain
bacteri
artifici
chromosom
facilit
genet
studi
larg
dna
viru
genom
review
recent
wagner
et
al
potenti
applic
numer
includ
basic
studi
viral
pathogenesi
gene
identif
character
develop
new
viral
vector
vaccin
effect
vaccin
avail
herp
simplex
viru
princip
caus
agent
genit
herp
furthermor
certain
whether
success
vaccin
develop
clear
type
vaccin
approach
eg
live
attenu
subunit
dna
like
success
consid
fig
antibodi
respons
follow
immun
gdbac
dna
mice
immun
ag
pbelobac
control
dna
dna
gdbac
dna
serum
sampl
collect
analyz
specif
igg
week
first
immun
week
follow
booster
immun
dose
dna
week
result
repres
experi
experi
similar
design
outcom
shown
erat
reason
advantag
bac
technolog
could
benefici
multipl
type
vaccin
studi
includ
construct
attenu
viru
strain
dna
vaccin
evalu
character
contribut
individu
viral
gene
gener
protect
immun
construct
bacteri
artifici
chromosom
follow
procedur
similar
describ
construct
bac
horsburgh
et
al
insert
sequenc
thymidin
kinas
gene
allow
select
recombin
viru
presenc
acyclovir
follow
isol
circular
dna
could
recov
bacteri
transform
procedur
result
thymidin
kinas
neg
phenotyp
thymidin
kinas
necessari
viral
virul
thu
import
viral
pathogenesi
studi
also
target
antivir
drug
acyclovir
ganciclovir
thu
would
import
safeti
featur
live
attenu
herpesviru
vaccin
construct
present
studi
envis
vaccin
per
se
rather
use
demonstr
feasibl
bac
immun
util
bac
manipul
viral
genom
hsv
vaccin
effect
evalu
vaccin
thorough
character
abil
induc
cellular
well
humor
immun
would
necessari
protect
capabl
multipl
relev
anim
model
would
need
assess
addit
live
viru
consid
use
vaccin
would
requir
demonstr
attenu
phenotyp
extens
character
bac
genom
includ
sequenc
analysi
genom
termini
reduc
impair
abil
establish
reactiv
latenc
function
thymidin
kinas
gene
safeti
reason
target
manipul
viral
genom
confer
attenu
impair
reactiv
latenc
could
easili
incorpor
candid
vaccin
bac
mutagenesi
preclin
studi
thymidin
kinas
neg
bac
viru
could
repair
insert
intact
thymidin
kinas
gene
anoth
locat
genom
rel
straightforward
procedur
recent
report
describ
altern
site
insert
bac
vector
sequenc
includ
intergen
region
u
l
u
l
gene
tanaka
et
al
addit
method
describ
allow
remov
bac
vector
sequenc
herpesviru
bac
smith
enquist
tanaka
et
al
wagner
et
al
clearli
avail
fulllength
infecti
clone
herpesvirus
techniqu
manipul
provid
power
tool
develop
new
gener
vaccin
one
major
goal
studi
report
determin
feasibl
immun
dna
two
immun
ag
dna
gene
gun
inocul
mice
result
robust
hsvspecif
igg
antibodi
respons
neutral
antibodi
respons
observ
variat
absolut
antibodi
titer
experi
eg
antibodi
titer
elicit
dna
immun
present
fig
like
due
particular
prepar
bac
dna
use
deliveri
experi
nevertheless
hsvspecif
antibodi
respons
follow
immun
reproduc
high
respons
consist
everi
anim
five
independ
experi
respond
detect
antibodi
data
shown
choic
ag
bac
dna
deliveri
gene
gun
arbitrari
base
consider
practic
eg
rel
small
amount
bac
dna
amount
infecti
viru
produc
dna
formal
demonstr
dna
infecti
follow
vivo
deliveri
infecti
viru
readili
produc
follow
vitro
deliveri
transfect
approxim
pfu
viru
produc
follow
transfect
ag
bac
dna
sinc
difficult
determin
amount
viru
produc
vivo
deliveri
dna
clear
vivo
deliveri
dna
effici
vitro
transfect
compar
vivo
deliveri
ag
bac
dna
two
concentr
viru
pfu
high
level
hsvspecif
igg
antibodi
respons
elicit
dna
immun
higher
dose
viru
inocul
p
respect
similarli
good
neutral
antibodi
respons
produc
immun
antibodi
isotyp
respons
elicit
group
qualit
similar
caution
observ
evalu
signific
antibodi
titer
neutral
titer
dnaand
virusinfect
anim
clearli
dose
respons
effect
depend
amount
live
viru
given
immun
fig
like
increas
dose
viru
would
produc
even
higher
level
specif
antibodi
also
attempt
doserang
studi
dna
importantli
result
indic
dna
strongli
immunogen
suggest
feasibl
viru
immun
dna
deliveri
assess
feasibl
dna
immun
replicationdefect
bac
gd
gene
elimin
mutagenesi
gd
gene
chosen
elimin
valid
power
bac
mutagenesi
procedur
construct
nonrepl
viru
mutant
delet
immunodomin
antigen
gd
would
provid
rigor
test
potenti
immunogen
bac
dna
elimin
essenti
gd
gene
rel
straightforward
requir
prior
construct
complement
cell
line
howev
vero
cell
line
express
gd
util
verifi
gdneg
phenotyp
produc
gdneg
viru
stock
difficulti
construct
cell
line
express
suffici
level
multipl
complement
gene
bac
mutagenesi
procedur
therefor
especi
use
mutagenesi
isol
viral
genom
contain
multipl
disabl
mutat
dna
immun
replicationdefect
bac
report
previous
suter
et
al
studi
packagingdefect
genom
clone
bac
fhsv
pac
saeki
et
al
induc
broad
immun
respons
protect
immun
mice
intracerebr
challeng
antibodi
respons
detect
one
gene
gun
immun
bac
dna
increas
second
third
immun
neutral
antibodi
detect
two
immun
like
gdbac
fhsv
pac
replic
produc
noninfecti
viruslik
particl
fhsv
pac
hand
express
entir
complement
gene
includ
gd
somewhat
difficult
compar
rel
protect
capac
immun
respons
elicit
packag
defect
bac
replicationcompet
incompet
bac
describ
studi
studi
bac
immun
compar
ghdelet
viru
studi
compar
bac
dna
immun
replic
viru
gener
bac
clone
gddelet
bac
nevertheless
fact
fundament
differ
hsv
bac
elicit
protect
immun
respons
least
anim
model
strongli
suggest
feasibl
bac
dna
immun
gene
gun
inocul
anim
gdbac
dna
elicit
hsvspecif
antibodi
neutral
antibodi
respons
lower
correspond
dna
respons
anim
still
protect
lethal
viru
challeng
result
complet
surpris
immun
hsv
purifi
gd
glycoprotein
gd
dna
produc
strong
humor
respons
gd
protect
nonetheless
immun
respons
hsv
complex
direct
mani
viral
antigen
addit
gd
mani
hsv
glycoprotein
elicit
antibodi
respons
protect
variou
anim
challeng
model
importantli
abil
systemat
sequenti
elimin
individu
multipl
antigen
use
bac
technolog
provid
power
tool
dissect
immun
respons
advantag
clone
larg
viral
genom
bac
numer
perhap
excit
abil
construct
recombin
genom
would
difficult
circumst
describ
previous
herpesvirus
brune
et
al
possibl
viral
vaccin
could
deliv
bac
dna
open
interest
possibl
could
facilit
vaccin
develop
deliveri
live
viru
via
bac
dna
prove
practic
technic
problem
associ
poor
growth
yield
mutat
viru
even
complement
cell
line
could
circumv
cours
issu
associ
largescal
product
bac
dna
would
address
obviou
advantag
confer
mainten
novel
viral
vaccin
stock
bac
dna
bacteri
stock
contain
recombin
bac
case
new
vaccin
stock
could
rederiv
requir
address
emerg
concern
regard
viru
seed
histori
materi
use
viru
stock
prepar
abil
rapidli
construct
novel
genom
use
bac
technolog
describ
facilit
develop
evalu
candid
vaccin
candid
vero
cell
obtain
american
type
cultur
collect
atcc
manassa
va
maintain
dulbecco
minim
essenti
medium
dmem
supplement
fetal
bovin
serum
fb
mm
mgml
gentamicin
gibcobrl
grand
island
ny
cell
vero
cell
line
express
gd
liga
johnson
gift
dr
david
c
johnson
depart
molecular
microbiolog
immunolog
oregon
health
scienc
univers
cell
maintain
suggest
eagl
mem
lack
histidin
mem
supplement
mm
histidinol
sigma
chemic
co
st
loui
fb
infect
cell
passag
two
time
dmem
contain
fb
strain
ms
herp
simplex
viru
origin
isol
brain
patient
multipl
sclerosi
obtain
atcc
plaquepurifi
propag
titrat
vero
cell
viral
dna
isol
describ
elsewher
denniston
et
al
construct
insert
plasmid
first
clone
two
region
thymidin
kinas
gene
clone
vector
promega
corpor
madison
wi
two
tk
fragment
made
pcr
amplif
genom
dna
templat
primer
sequenc
design
base
publish
data
strain
dolan
et
al
consist
bp
tk
code
sequenc
plu
addit
kb
downstream
sequenc
amplifi
primer
tka
atctcgagccccatgaagcccttcccg
coordin
tkb
ggaagcttgacccc
ccaggccgtgttg
coordin
incorpor
xhoi
hindiii
site
bold
respect
primer
sequenc
consist
bp
tk
code
sequenc
plu
addit
kb
upstream
flank
sequenc
amplifi
primer
tkc
gaggtaccgcgcg
coordin
tkd
coordin
incorpor
hindiii
xbai
bold
site
respect
primer
clone
strategi
result
intermedi
insert
plasmid
contain
approxim
kb
tk
gene
locu
flank
sequenc
uniqu
hindiii
restrict
site
near
middl
tk
code
region
hindiii
restrict
site
posit
allow
easi
insert
linear
vector
research
genet
huntsvil
al
gener
authent
construct
confirm
sequenc
dna
sequenc
appli
biosystem
foster
citi
ca
pcr
product
initi
clone
use
zero
blunt
topo
pcr
clone
kit
invitrogen
carlsbad
ca
routin
isol
purif
plasmid
perform
use
qiagen
plasmid
purif
kit
protocol
describ
manufactur
qiagen
inc
valencia
ca
construct
glycoprotein
gd
delet
replac
vector
amplifi
two
region
gd
gene
pcr
clone
fragment
clone
vector
promega
one
fragment
consist
bp
immedi
upstream
first
atg
gdcode
sequenc
second
fragment
consist
bp
immedi
downstream
end
gdcode
sequenc
approxim
region
gdcode
sequenc
delet
transfer
gateway
entri
vector
invitrogen
result
plasmid
construct
use
transfer
gd
region
bac
gene
replac
vector
yield
bac
mutagenesi
vector
deriv
previous
describ
gene
replac
vector
horsburgh
et
al
horsburgh
et
al
modifi
use
gateway
destin
vector
insert
gene
cassett
contain
attr
recombin
site
multipl
clone
region
manuscript
prepar
mutagenesi
essenti
describ
previous
horsburgh
et
al
horsburgh
et
al
briefli
electrocompet
cell
transform
dna
select
chloramphenicol
resist
electropor
condit
employ
cuvet
btx
san
diego
ca
set
transpor
plu
btx
clone
confirm
pcr
three
independ
specif
primer
pair
primer
pair
amplifi
fragment
chloramphenicol
acetyltransferas
cat
gene
electrocompet
cell
harbor
bac
prepar
previous
describ
ausubel
et
al
electrocompet
cell
contain
electropor
ng
dna
plate
onto
chloramphenicolzeocin
camzeo
plate
serial
dilut
jc
follow
day
multipl
coloni
pick
ml
lb
broth
plate
serial
dilut
onto
camzeo
plate
jc
coloni
jc
analyz
pick
sever
ml
lb
immedi
plate
al
onto
sucros
chloramphenicol
succam
plate
jc
approxim
coloni
plate
repres
origin
jc
coloni
transfer
grid
suczeo
cam
lb
plate
jc
coloni
grew
cam
plate
zeosuc
ie
cam
zeosuc
pick
al
mm
tri
ph
coloni
pcr
use
specif
primer
along
primer
pair
flank
gdcode
region
posit
coloni
streak
onto
cam
plate
grown
jc
clone
grown
camlb
media
glycerol
stock
subsequ
larg
prepar
gdbac
dna
use
larg
construct
kit
qiagen
inc
balbcbyj
mice
purchas
jackson
laboratori
bar
harbor
hous
cage
core
facil
center
biolog
evalu
research
cber
bethesda
md
steril
food
drink
water
suppli
ad
libitum
gener
care
handl
procedur
perform
accord
protocol
approv
anim
care
use
committe
cberfda
mice
use
experi
week
age
agematch
within
experi
dna
immun
gene
gun
inocul
intraperiton
challeng
perform
previous
describ
meseda
et
al
live
viru
immun
intraderm
inject
base
tail
detect
antibodi
hsv
glycoprotein
elisa
pachl
et
al
perform
previous
describ
meseda
et
al
nass
et
al
use
mixtur
glycoprotein
inactiv
cell
extract
endpoint
titer
defin
highest
dilut
serum
gave
valu
greater
match
dilut
normal
preble
mous
serum
also
greater
neutral
antibodi
assay
perform
use
plate
contain
vero
cell
pfu
per
well
previous
describ
meseda
et
al
nass
et
al
sera
assay
individu
mice
within
group
test
n
signific
differ
antibodi
titer
group
defin
p
analyz
use
unpair
twotail
student
test
instat
softwar
graphpad
softwar
signific
differ
surviv
challeng
group
mice
analyz
use
fisher
exact
test
instat
softwar
